The effect of terazosin and tolterodine on ureterl stent related symptoms
Phase 2
- Conditions
- reteral stent (Double-J stent) related symptoms.Calculus of kidney, Calculus of ureter, Calculus of kidney with calculus of ureter, Hydronephrosis with ureteropelvic junction obstructionN20, N20.1
- Registration Number
- IRCT201111255786N2
- Lead Sponsor
- Vicechancellor for research, Urmia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Exclusion criteria:?
?1)?? ?Prior history of pelvic surgery? ?
?2) Prior history of Transurethral Resection of the either Prostate or Bladder Tumor
?3) Benign prostate hyperplasia?
?4) Recent or recurrent urinary tract infection
?5) Chronic medication with ?-blockers or Anti-cholinergic
?6) Pregnancy?
?7) Prostatitis
?8) Prostate cancer?
?9) Bilateral ureteroscopy or ureteral stenting?
?10) Age >18 and <55
?11) Stone size >20 mm?
?12) Diabetes?
?13??) Bladder Outlet Obstruction
If a patient dose not meet any exclusion criteria and to be undergone double-J stent indwelling.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ower Urinary Tract Symptoms. Timepoint: before intervention, 14days after intervention, stent removal time. Method of measurement: IPSS(International Prostate Symptom Score) and VAS(Visual Analogue Scale).
- Secondary Outcome Measures
Name Time Method Drug complications. Timepoint: Stent removal time. Method of measurement: Getting history from patient.;Amount of analgesic consumption. Timepoint: Stent removal time. Method of measurement: Getting history from patient.